RecallDepth
Class II Terminated

Arformoterol Tartrate Inhalation Solution, 15 mcg/2mL, 2 mL Sterile Unit-Dose Vial packaged in 5 x 2 mL Sterile Unit-Dose Vials per pouch, NDC 69097-168-48; 60 (12 x 5) x 2 mL Sterile Unit-Dose Vials per carton, NDC 69097-168-64, Rx Only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059.

Company
Cipla
Recall Initiated
September 29, 2022
Posted
October 12, 2022
Recall Number
D-1550-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
9041 cartons
Firm Location
Warren, NJ, United States

Reason for Recall

Lack of Assurance of Sterility: environmental monitoring failure.

Distribution

Product was distributed nationwide to distributors/wholesalers who may have further distributed the product.

Lot / Code Info

Batch No: IA10082, IA10083, IA10084, IA10085, IA10086, exp. date 01/2023; IA10122, IA10123, IA10124, IA10125, IA10126, IA10127, IA10128, IA10129, IA10130, exp. date 02/2023

More recalls by Cipla

View all recalls by this company →

Other recent Class II Drug recalls